You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogens, Conjugated (USP)

Showing 501 - 525 of 539
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Montreal (Zidovudine 300mg tablets)

Completed
  • Healthy
  • Zidovudine 300mg tablets
  • Montreal, Quebec, Canada
    MDS Pharma Services
Oct 23, 2008

Healthy Trial in Saint-Laurent, Montreal (cefprozil 500mg tablets)

Completed
  • Healthy
  • cefprozil 500mg tablets
  • Saint-Laurent, Montreal, Quebec, Canada
    MDS Pharma Services
Oct 22, 2008

Healthy Trial in Montreal (cefprozil 500mg tablets)

Completed
  • Healthy
  • cefprozil 500mg tablets
  • Montreal, Quebec, Canada
    MDS Pharma Services
Oct 22, 2008

Vaginal Atrophy Trial in United States (Bazedoxifene/Conjugated Estrogen)

Completed
  • Vaginal Atrophy
  • Bazedoxifene/Conjugated Estrogen
  • Birmingham, Alabama
  • +62 more
Dec 19, 2007

Healthy Trial in Gurgaon (Cyclobenzaprine HCl 10 mg tablet)

Completed
  • Healthy
  • Cyclobenzaprine hydrochloride 10 mg tablet
  • Gurgaon, Haryana, India
    Ranbaxy CPU
Oct 22, 2008

Bipolar Disorder, Mania, Schizoaffective Disorder Trial in Melbourne (Tamoxifen, Progesterone, )

Completed
  • Bipolar Disorder
  • +2 more
  • Melbourne, Victoria, Australia
    Bayside Health - The Alfred Hospital
Oct 23, 2008

Parkinson's Disease Trial in United States (Premarin ®)

Completed
  • Parkinson's Disease
  • Premarin ®
  • Sunnyvale, California
  • +5 more
Dec 24, 2007

Vasomotor Symptoms Associated With Menopause Trial in United States (Bazedoxifene/Conjugated Estrogen)

Completed
  • Vasomotor Symptoms Associated With Menopause
  • Bazedoxifene/Conjugated Estrogen
  • Phoenix, Arizona
  • +6 more
Dec 19, 2007

Estrogen Replacement Therapy Trial (conjugated estrogens/progestin (MPA))

Completed
  • Estrogen Replacement Therapy
  • conjugated estrogens/progestin (MPA)
  • (no location specified)
Dec 4, 2007

Pharmacogenetics and Cardiovascular Events

Completed
  • Cardiovascular Diseases
  • +4 more
    • (no location specified)
    Aug 20, 2008

    Menopause Trial in United States (esterified estrogens 1.25 mg and methyltestosterone 2.5 mg, Esterified estrogens 1.25 mg)

    Terminated
    • Menopause
    • esterified estrogens 1.25 mg and methyltestosterone 2.5 mg
    • Esterified estrogens 1.25 mg
    • Huntsville, Alabama
    • +77 more
    Apr 10, 2008

    Menopause Trial in United States (esterified estrogens 1.25mg and methyltestosterone 2.5mg, Esterified estrogens 1.25 mg)

    Terminated
    • Menopause
    • esterified estrogens 1.25mg and methyltestosterone 2.5mg
    • Esterified estrogens 1.25 mg
    • Huntsville, Alabama
    • +77 more
    Apr 10, 2008

    Tolerability & Safety of Premarin Vaginal Cream in Indian

    Completed
    • Postmenopause
    • Conjugated Estrogen Cream (Premarin®)
    • (no location specified)
    Dec 20, 2007

    Postmenopause Trial in Miami (Premarin/MPA 0.45 mg/1.5 mg)

    Completed
    • Postmenopause
    • Premarin/MPA 0.45 mg/1.5 mg
    • Miami, Florida
      (unnamed)
    Dec 4, 2007

    Healthy Trial in Tacoma (Nitroglycerin)

    Completed
    • Healthy
    • Tacoma, Washington
      Charles River Clinical Services
    Apr 8, 2008

    Leukemia, T-Cell, Lymphoma, T-Cell, Cutaneous Trial run by the NCI (Yttrium-90 radiolabeled anti-Tac antibody)

    Completed
    • Leukemia, T-Cell
    • Lymphoma, T-Cell, Cutaneous
    • Yttrium-90 radiolabeled anti-Tac antibody
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Mar 3, 2008

    Menopause Trial (bazedoxifene/conjugated estrogens)

    Completed
    • Menopause
    • bazedoxifene/conjugated estrogens
    • (no location specified)
    Mar 12, 2007

    Atrophic Vaginitis, Atrophy, Vaginitis Trial in Canada, United States (PVC (daily for 21 days, 7 days off), PVC (twice weekly))

    Completed
    • Atrophic Vaginitis
    • +2 more
    • PVC (daily for 21 days, 7 days off)
    • PVC (twice weekly)
    • Tucson, Arizona
    • +48 more
    Dec 7, 2007

    Postmenopausal Osteoporosis, Postmenopause Trial (Formulations A and B of Premarin/MPA 0.45 mg/0.5 mg and PREMPRO0.45 mg/0.5 mg)

    Completed
    • Postmenopausal Osteoporosis
    • Postmenopause
    • Formulations A and B of Premarin/MPA 0.45 mg/0.5 mg and PREMPRO0.45 mg/0.5 mg
    • (no location specified)
    Jun 8, 2007

    Atrophic Vaginitis Trial in Miami, Baltimore (Premarin® Vaginal Cream, Premarin® oral tablets)

    Completed
    • Atrophic Vaginitis
    • Premarin® Vaginal Cream
    • Premarin® oral tablets
    • Miami, Florida
    • +1 more
    May 25, 2007

    GVHD, Multiple Myeloma Trial run by the NCI (Myeloma Immunoglobulin Idiotype Vaccine-KLH, GM-CSF)

    Completed
    • Graft vs Host Disease
    • Multiple Myeloma
    • Myeloma Immunoglobulin Idiotype Vaccine-KLH
    • GM-CSF
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Sep 21, 2007

    Systemic Lupus Erythematosus Trial in Mexico (Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d)

    Completed
    • Systemic Lupus Erythematosus
    • Conjugated equine estrogens 0.625 mg/d + MPA 5 mg/d/10d
    • Mexico, Mexico
      I
    Oct 23, 2006

    Healthy Trial in Amsterdam, Wageningen (consumption of CLA enriched food)

    Completed
    • Healthy
    • consumption of CLA enriched food
    • Amsterdam, Netherlands
    • +1 more
    Jul 5, 2007

    Sarcopenia Trial in Hamilton (Training, Creatine Monohydrate, Conjugated Linoleic Acid)

    Completed
    • Sarcopenia
    • Training
    • Creatine Monohydrate, Conjugated Linoleic Acid
    • Hamilton, Ontario, Canada
      McMaster University Medical Center
    May 15, 2007

    Four New Formulations for Premarin in Healthy Postmenopausal

    Completed
    • Postmenopause
    • (no location specified)
    Sep 26, 2006